share_log

HC Wainwright & Co. Upgrades Context Therapeutics to Buy, Announces $5 Price Target

HC Wainwright & Co. Upgrades Context Therapeutics to Buy, Announces $5 Price Target

HC Wainwright & Co.将Context Therapeutics升级为收购,宣布5美元的目标
Benzinga ·  2023/11/01 07:17

HC Wainwright & Co. analyst Emily Bodnar upgrades Context Therapeutics (NASDAQ:CNTX) from Neutral to Buy and announces $5 price target.

HC Wainwright & Co. 分析师艾米丽·博德纳尔将Context Therapeutics(纳斯达克股票代码:CNTX)从中性上调至买入,并宣布了5美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发